|
0
|
|
VIBRANT: A phase 1 randomized trial of multi-strain vaginal L. crispatus live biotherapeutic products in people with bacterial vaginosis.
(linkinghub.elsevier.com)
|
Potloane D
…
Mitchell CM
Cell Host & Microbe
2026-04-08
|
#microbiome
#metagenomics
#dysbiosis
#probiotic
#colonization
|
|
0
|
|
Antibiotic-induced microbiota disruption impairs neutrophil-mediated immunity to respiratory Aspergillus fumigatus infection in mice.
(journals.asm.org)
|
Aufiero MA
…
Hohl TM
mBio
2026-04-08
|
#microbiome
#infection
#immunity
#dysbiosis
#inflammation
|
|
0
|
|
Vaginal microbiota impacts of a Lactobacillus crispatus live biotherapeutic and predictors of colonization in randomized controlled trial.
(linkinghub.elsevier.com)
|
Bloom SM
…
Kwon DS
Cell Host & Microbe
2026-04-08
|
#microbiome
#dysbiosis
#inflammation
#probiotic
#colonization
|
|
0
|
|
Crisping up Lactobacillus vaginal live biotherapeutics.
(linkinghub.elsevier.com)
|
van de Wijgert JHHM
Cell Host & Microbe
2026-04-08
|
#microbiome
#dysbiosis
#probiotic
#colonization
|
|
0
|
|
Gut microbiota immaturity with DL-endopeptidase deficiency links antibiotic use to preterm late-onset sepsis.
(linkinghub.elsevier.com)
|
Shen W
…
He Y
Cell Host & Microbe
2026-04-08
|
#microbiome
#immunity
#dysbiosis
#probiotic
#sepsis
|
|
0
|
|
Quantifying artificial sweeteners and emulsifiers in Crohn's disease and its relationship with disease activity: the ENIGMA study - a novel and targeted approach.
(gut.bmj.com)
|
Zhang J
…
Ng SC
Gut
2026-04-08
|
#microbiome
#metabolism
#dysbiosis
#inflammation
#crohn's disease
|
|
0
|
|
Dietary fiber fermentation restores microbiome resilience to oxygen stress in a host-independent ex vivo model.
(journals.asm.org)
|
Gong Y
…
Ghosh S
mBio
2026-04-08
|
#microbiome
#metabolism
#dysbiosis
#sequencing
#resilience
|